Featured Research

from universities, journals, and other organizations

Small Variations In Genes Can Determine Risk Of Developing Breast Cancer

Date:
December 17, 2004
Source:
NIH/National Cancer Institute
Summary:
A woman's risk of developing breast cancer is due in part to a group of very small variations in genes which code for a cell's estrogen receptors, according to a new study.

A woman's risk of developing breast cancer is due in part to a group of very small variations in genes which code for a cell's estrogen receptors, according to a collaborative study by scientists at the National Cancer Institute (NCI), part of the National Institutes of Health, Memorial Sloan-Kettering Cancer Center, Celera Diagnostics, SAIC-Frederick Inc., Applied Biosystems, the Massachusetts Institute of Technology and Vanderbilt University School of Medicine. The study appears in the December 15, 2004, issue of Cancer Research*.

Many breast cancers depend on estrogen and progesterone to grow. Cells in these cancers have proteins called estrogen and progesterone receptors on their surface. Receptors are an outside molecule's gateway to the cell: molecules bind to and sometimes pass through receptors into the cell. In breast cancers dependent on these two steroid hormones to grow, estrogen and progesterone bind to their respective receptors, initiating signaling pathways that cause the cancer cells to multiply.

Researchers led by Bert Gold, Ph.D., a scientist in NCI's Center for Cancer Research, studied the association between breast cancer risk and very small differences in the genes coding for estrogen and progesterone receptors. Called "single nucleotide polymorphisms," these versions of the gene differ by a single nucleotide — the molecular subunit of DNA. Though these differences are small, they can have an impact on how an estrogen receptor performs.

NCI scientists examined connections between an estrogen receptor gene, called ESR1, and breast cancer. Of 17 single nucleotide polymorphisms (variations) of ESR1 under study, there were two polymorphisms associated with breast cancer susceptibility. One was associated with disease only in women over 50; additionally, this polymorphism was very rare in the African-American population. The other polymorphism was associated with disease only in Ashkenazi (Central or Eastern European) Jewish women over 50.

The researchers found that a group of single nucleotide polymorphisms in the third most common ESR2 gene in Ashkenazi women under study was associated with breast cancer susceptibility. This is one of the first studies to examine breast cancer susceptibility and ESR2 polymorphisms since the discovery of ESR2 in 1996. They studied eight other polymorphisms in ESR2 and found no groups of polymorphisms associated with disease in the general population.

Gold and his colleagues also found no association between breast cancer and 13 single nucleotide polymorphisms in the progesterone receptor gene.

The study population included DNA samples from 1,006 women with breast cancer (identities were masked) who were patients at Memorial Sloan-Kettering in New York City and 613 control subjects from 14 sites that are part of the New York Cancer Study. The two groups had similar proportions of women over and under 50 and of women who had menopause before or after age 50. Case and control groups also contained similar proportions of women in six ethnic groups: those of European, African, Asian, Hispanic, Ashkenazi, and unknown descent.

There is good news for some women. "We were pleasantly surprised to discover that some women have some genetic protection from breast cancer," said Gold. Three groups of single nucleotide polymorphisms in the ESR1 gene protected against the risk of the disease across the ethnic and age groups. However, only one of these was protective when NCI scientists examined only European-Americans.

"We know that half of familial breast cancer is due to genetic factors other than BRCA1 and BRCA2," said Kenneth Offit, M.D., a cancer geneticist at Memorial Sloan-Kettering and a co-author of the study. "These findings suggest that genetic variants in estrogen receptor pathways may be one of many such risk factors."

"Hormone receptors are also the target of several anticancer drugs," said Michael Dean, Ph.D., NCI, another co-author of the report. "We hope pharmaceutical developers will take our results into account as they develop new drugs that modulate the effects of estrogen on breast cancer cells."

For more information about cancer, visit the NCI Web site at http://www.cancer.gov or call NCI's Cancer Information Service at 1-800-4-CANCER (1-800-422-6237).

###

* Gold B, Kalush F, Bergeron J, Scott K, Mitra K, Wilson K, Ellis N, Huang H, Chen M, Lippert R, Halldorsson BV, Woodworth B, White T, Clark AG, Parl FF, Broder S, Dean M, and Offit K. Estrogen receptor genes and haplotypes associated with breast cancer risk. Cancer Research, 64. Dec. 15, 2004.


Story Source:

The above story is based on materials provided by NIH/National Cancer Institute. Note: Materials may be edited for content and length.


Cite This Page:

NIH/National Cancer Institute. "Small Variations In Genes Can Determine Risk Of Developing Breast Cancer." ScienceDaily. ScienceDaily, 17 December 2004. <www.sciencedaily.com/releases/2004/12/041217102640.htm>.
NIH/National Cancer Institute. (2004, December 17). Small Variations In Genes Can Determine Risk Of Developing Breast Cancer. ScienceDaily. Retrieved October 21, 2014 from www.sciencedaily.com/releases/2004/12/041217102640.htm
NIH/National Cancer Institute. "Small Variations In Genes Can Determine Risk Of Developing Breast Cancer." ScienceDaily. www.sciencedaily.com/releases/2004/12/041217102640.htm (accessed October 21, 2014).

Share This



More Health & Medicine News

Tuesday, October 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

CDC Revamps Ebola Guidelines After Criticism

CDC Revamps Ebola Guidelines After Criticism

Newsy (Oct. 21, 2014) The Centers for Disease Control and Prevention have issued new protocols for healthcare workers interacting with Ebola patients. Video provided by Newsy
Powered by NewsLook.com
First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

Newsy (Oct. 21, 2014) A medical team has for the first time given a man the ability to walk again after transplanting cells from his brain onto his severed spinal cord. Video provided by Newsy
Powered by NewsLook.com
CDC Issues New Ebola Guidelines for Health Workers

CDC Issues New Ebola Guidelines for Health Workers

Reuters - US Online Video (Oct. 21, 2014) The U.S. Centers for Disease Control and Prevention has set up new guidelines for health workers taking care of patients infected with Ebola. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
'Cadaver Dog' Sniffs out Human Remains

'Cadaver Dog' Sniffs out Human Remains

AP (Oct. 21, 2014) Where's a body buried? Buster's nose can often tell you. He's a cadaver dog, specially trained to find human remains and increasingly being used by law enforcement and accepted in courts. These dogs are helping solve even decades-old mysteries. (Oct. 21) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins